The latest thoracic oncology news
Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection of…
Radiation or surgical removal of metastatic tumours provides a major survival advantage for lung cancer…
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive…
A recent survey found lung cancer survivors indicate that emotional effects, unlike physical impacts, are…
Patients treated with more-invasive surgical techniques for a type of early-stage lung cancer are more…
Women diagnosed with non-small cell lung cancers (NSCLC) live longer than their male counterparts, according…
Findings from a recent study demonstrate that the use of atezolizumab, a PD-L1 inhibitor, in…
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive…
Findings from a recent study demonstrate that female lung cancer patients who have never smoked…
A new study suggests chemotherapy may cause acute amenorrhea leading to early menopause in women…